Development of a framework for risk assessment of dietary carcinogens.

Cancer risk assessment Carcinogenicity Dietary carcinogens Exposure assessment Genotoxicity Mode of action Mutagenicity

Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 12 09 2022
revised: 09 08 2023
accepted: 01 09 2023
medline: 9 10 2023
pubmed: 17 9 2023
entrez: 16 9 2023
Statut: ppublish

Résumé

Although there are a number of guidance documents and frameworks for evaluation of carcinogenicity, none of the current methods fully reflects the state of the science. Common limitations include the absence of dose-response assessment and not considering the impact of differing exposure patterns (e.g., intermittent, high peaks vs. lower, continuous exposures). To address these issues, we have developed a framework for risk assessment of dietary carcinogens. This framework includes an enhanced approach for weight of evidence (WOE) evaluation for genetic toxicology data, with a focus on evaluating studies based on the most recent testing guidance to determine whether a chemical is a mutagen. Included alongside our framework is a discussion of resources for evaluating tissue dose and the temporal pattern of internal dose, taking into account the chemical's toxicokinetics. The framework then integrates the mode of action (MOA) and associated dose metric category with the exposure data to identify the appropriate approach(es) to low-dose extrapolation and level of concern associated with the exposure scenario. This framework provides risk managers with additional flexibility in risk management and risk communication options, beyond the binary choice of linear low-dose extrapolation vs. application of uncertainty factors.

Identifiants

pubmed: 37716495
pii: S0278-6915(23)00424-6
doi: 10.1016/j.fct.2023.114022
pii:
doi:

Substances chimiques

Carcinogens 0
Mutagens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114022

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Christopher A Bates (CA)

ChemRisk (Stantec), USA. Electronic address: christopher.bates@stantec.com.

Lynne T Haber (LT)

Risk Science Center, University of Cincinnati College of Medicine, USA.

Martha M Moore (MM)

Martha M. Moore LLC, USA.

Rita Schoeny (R)

Rita Schoeny LLC, USA.

Andrew Maier (A)

ChemRisk (Stantec), USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH